Search results
Results from the WOW.Com Content Network
Chronic bacterial prostatitis is thought to be caused by ascending urethral infection and by reflux into the ejaculatory duct or prostatic ducts. [7] Risk factors for chronic bacterial prostatitis include functional or anatomic abnormalities, catheterization, prostate biopsy or urethritis (due to sexually transmitted infections), and unprotected penetrative anal sex. [7]
[30] [31] [32] As such, nitrofurantoin is not recommended for eradication of chronic bacterial prostatitis. [33] In any case, in men with antibiotic-refractory or relapsing chronic bacterial prostatitis, prophylactic nitrofurantoin may be useful in preventing UTIs and managing symptoms. [30] [34] [35] However, supporting data are lacking as of ...
The role of the prostate was questioned in the cause of CP/CPPS when both men and women in the general population were tested using the (1) National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI [92]) – with the female homologue of each male anatomical term used on questionnaires for female participants – (2) the ...
[7] [8] Doses of methenamine of up to 10 to 20 g/day have also been studied and found to be tolerable without major toxicity. [7] When methenamine was first introduced in the late 1800s and early 1900s, doses of 15 to 30 g per day were commonly employed and doses of up to 60 to 180 g per day were tried in some cases. [42]
Ofloxacin is a quinolone antibiotic useful for the treatment of a number of bacterial infections. [1] When taken by mouth or injection into a vein, these include pneumonia, cellulitis, urinary tract infections, prostatitis, plague, and certain types of infectious diarrhea.
The CDC is proposing that health providers offer a single 200-milligram dose of doxycycline to gay and bisexual men who have sex with… CDC proposes antibiotic as morning-after STI treatment for ...
[37] [50] In fact, the incidence of diarrhea did not differ between the bicalutamide and placebo groups (6.3% vs. 6.4%, respectively) in the Early Prostate Cancer (EPC) clinical trial programme, [51] whereas diarrhea occurs in up to 20% of patients treated with flutamide.
Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. [9] [10] Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA).